Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000032

CEO bought 43,000 shares at an average $0.01 ($472)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-20 Purchase : show line 1 in the form +5,000 $0.01 $59 21,839,397 D
2019-05-20 Purchase : show line 2 in the form +1,000 $0.01 $11 21,840,397 D
2019-05-21 Purchase : show line 3 in the form +5,000 $0.01 $55 21,845,397 D
2019-05-21 Purchase : show line 4 in the form +10,000 $0.01 $110 21,855,397 D
2019-05-21 Purchase : show line 5 in the form +5,000 $0.01 $53 21,860,397 D
2019-05-21 Purchase : show line 6 in the form +5,000 $0.01 $55 21,865,397 D
2019-05-21 Purchase : show line 7 in the form +5,000 $0.01 $55 21,870,397 D
2019-05-21 Purchase : show line 8 in the form +5,000 $0.01 $54 21,875,397 D
2019-05-21 Purchase : show line 9 in the form +2,000 $0.01 $22 21,877,397 D
Open-market purchases · 43,000 sh · avg $0.01 · $472
Loading xslF345X03/primary_doc.xml…